Nestlé stock at CHF 77.17 on September 25, 2026

Nestlé is preparing a change in its senior legal leadership while continuing to reshape its portfolio. The company’s Board of Directors appointed Manuela Bernasconi as Group General Counsel and a member of the Group Executive Board, effective January 1, 2027. The appointment was announced on September 24, 2026, in a Nestlé press release.

Leadership transition

Bernasconi currently serves as General Counsel for Zone Americas. In her new role, she will take responsibility for Nestlé’s Group Legal and Compliance function and join the company’s executive leadership body at the start of 2027. The change is part of a planned transition rather than an immediate change, with the effective date specified by Nestlé in its announcement.

Bernasconi joined Nestlé in 2007 as Legal Counsel in Corporate and Group Compliance. She later held legal leadership positions in Zone Europe and Nestlé Switzerland before joining Nespresso in 2017. Nestlé appointed her General Counsel for Nespresso in 2020, followed by a role as General Counsel for Zone Latin America and her appointment to lead legal affairs for Zone Americas in January 2025. These career details were provided in the company release.

Leanne Geale, Nestlé’s Group General Counsel for seven years, will retire at the end of 2026. The company said Geale strengthened and professionalized its Legal and Compliance function during her tenure, including its approach to human rights. Nestlé CEO Philipp Navratil described Bernasconi as an experienced internal candidate with legal, regulatory and compliance expertise in the September 24 announcement.

Vitamins and supplements divestment

Separately, Nestlé agreed on September 1, 2026, to divest its mainstream Vitamins, Minerals and Supplements business, known as the Holistic Health portfolio, to Yellow Wood Partners. The agreed consideration is USD 1.0 billion, equivalent to CHF 0.8 billion, according to Nestlé’s original release.

The transaction remains subject to applicable regulatory approvals and is expected to close by the first half of 2027. Nestlé said the scope includes Nature’s Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan’s Pride and Sisu, along with the associated US private-label supplements business and dedicated manufacturing, packaging, warehousing and distribution operations. The business generated USD 1.2 billion in sales in 2025, or CHF 1.0 billion, the company reported in its divestment announcement.

Nestlé said the mainstream VMS business predominantly operates in the United States, with a presence in several other countries including Canada and China. The company described the sale as part of its strategic portfolio transformation and said it is focusing resources on areas where it has the strongest competitive advantage. Nestlé also pointed to its premium, science-led VMS brands, including Solgar and Pure Encapsulations, in the company’s release.

Stock performance

Nestlé S.A. last traded at CHF 77.17 on SIX Swiss Exchange on September 25, 2026, at 15:30:53 UTC. The share was down CHF 0.77, or 0.99 percent, from the previous close of CHF 77.94.

Nestlé company stock